• Stocks
  • Commodities
  • Cryptocurrency
  • Forex
  • Real Estate Investing
  • Other Categories
    • Investing Reviews
    • Business
    • Career
    • Credit
    • Debt
    • Financial Advice
    • Investing
    • Real Estate
    • Retirement
    • Modest Money Facebook
    • Modest Money Twitter
    • Modest Money LinkedIn
    • Modest Money RSS Feed

Modest Money

Personal Finance Blog for Everyday People

  • Breaking Investment News
    • All Investing News
    • Commodities News
    • Currencies News
    • Stock Market News
    • Real Estate Investing
  • Hot Investing Tips
    • Using The Graham Formula to Find Underpriced Stocks
    • Why Dividend Growth Investing Works
    • Understanding Your Place in Bull and Bear Markets
    • How a Catalyst Turns into Dollar Signs
    • The Truth About Binary Options – Legit Trading or Scam?
  • Top Investing Books
    • Top 3 Trading Books
    • The Best Books For New Investors
    • The Top 3 Books on House Flipping
  • Recommended Investing Resources
    • Favorite Resources
    • Ally Invest Review
    • Betterment Review
    • Lending Club Review
    • Personal Capital Review
    • TD Ameritrade Review
    • Financial Product Reviews

Metabolix (MBLX) Stock: Skyrocketing on Asset Sale

Metabolix, Inc. (NASDAQ: MBLX)


Metabolix is having an incredible day in the market today, and for good reason. The company announced the sale of assets that will drive strong revenue. Today, we’ll talk about the sale, how the stock reacted to the news, and what we can expect to see from MBLX moving forward. So, let’s get right to it…

MBLX Soars On LOI

Early this morning, Metabolix announced that it had entered into a binding letter of intent (LOI). The LOI is with CJ Cheiljedang Corporation and it surrounds the sale of intellectual property and certain laboratory equipment. In the announcement, the company announced that it has committed to the sale of its biopolymer IP.

The sale of the intellectual property and laboratory equipment will come with a price tag of $10 million. Of the $10 million, $2 million was already paid to MBLX upon the execution of the letter of intent. The other $8 million included in the transaction is payable at closing. It is expected that the transaction will come to a close in mid-September.

Under the agreement between the companies, MBLX ill transfer a portfolio of IP including the platform microbial strains that it has used to produce fermentation based products, as well as patent rights covering the production and use of PHA biopolymers. Also, the sale of the assets is expected to include a sublease to CJ of a portion of the company’s Woburn, Mass., facility. In a statement, Joseph Shaulson, President and CEO at Metabolix had the following to offer….

“We believe this transaction will help put the Company on a more stable footing and enable us to move forward with our plan to make Yield10 Bioscience our core business… We are excited about our new direction and look forward to focusing our efforts on developing disruptive technologies for step-change improvements in crop yield.”

How The Stock Reacted To The News

As investors, one of the first things that we learn is that it’s important to watch the news. After all, any news surrounding a publicly traded company will likely lead to movement. Obviously, positive news will lead to positive moves while negative news leads to negative moves. The news today was overwhelmingly positive. Not only will the new deal drive $10 million in revenue, it will also help the company create a fine tuned focus around a key product. As a result, we’re seeing strong gains in the value of the stock today. Currently (3:12), MBLX is trading at $0.46 per share after a gain of $0.07 per share or 18.94% thus far today.

What We Can Expect To See Moving Forward

Moving forward, I have an incredibly bullish opinion of what we can expect to see from MBLX. The company has recently been selling assets and restructuring in order to make the Yield 10 Bioscience its core business. This is the last phase of this restructuring which will allow crystal clear focus on this promising asset. All in all, I’m expecting to see gains ahead.

What Do You Think?

Where do you think MBLX is headed moving forward? Join the discussion in the comments below!

Tweet
Share
Pin
Share
+1
0 Shares

Metabolix (MBLX) Stock: Skyrocketing on Asset Sale

Recent Posts from Modest Money

  • Shaw Communications: High-Yield Canadian Stock Paying Monthly Dividends
  • Only 6 Months Left to Claim PPI
  • The LRS – Liberalized Remittance Scheme
  • GigaFX – How Does it Compare with Other Online Brokers
  • ExxonMobil (NYSE:XOM) is Pretty Cheap, But is it a Good Buy?
  • Could Red Dead Redemption 2 be Killing Market Performance of Take-Two Interactive Software Inc. (TTWO)?
  • Galaxy Next Generation (GAXY) Stock: Leading The Way In Education Technology
  • Five Investments That Preserve Capital, Reduce Risk
  • Troubled Cryptocurrency Exchange Files for Protection
  • How to Choose a Financial Advisor

August 23, 2016 by Josh Rodriguez Leave a Comment

Filed Under: All Recent Investing News, All Stock Market News Tagged With: MBLX

About the Author:Josh Rodriguez

Joshua Rodriguez is the owner and founder of CNA Finance. He is also a partner here at Modest Money. His analysis has been featured on Investing.com, Yahoo! Finance, Google Finance, Google News, and many others. To connect with Joshua, follow him on Twitter @CNAFinance.

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Most Popular:

  • Ally investing review
    Ally Invest Review
  • betterment investing review
    Betterment Review
  • Underpriced Stocks Graham Formula
    Top 3 Trading Books Every Trader Should Read
  • Underpriced Stocks Graham Formula
    How to Find Underpriced Stocks Using The Graham Formula
  • Investment Diversification
    Investment Diversification: 5 Risky Mistakes to Avoid
  • dividend growth investing
    Why Dividend Growth Investing Works
  • binary options scam
    The Truth About Binary Options - Legit Trading or Scam?
  • Investing for the Long Term
    Investing for the Long Term: Understanding Your Place in Bull and Bear Markets
  • Should investors buy individual stocks or index funds
    Should Investors Buy Individual Stocks or Index Funds

newsletter

Modest Money Investing News

© 2018 ModestMoney.com – All Rights Reserved.

  • Blog Advertising
  • About us
  • Blogroll
  • Top Finance Blogs
  • Disclaimer
  • Privacy Policy
  • Contact
  • Sitemap